Skip to main content
Signal8

Romano Sarah

SEC insider (Form 3/4/5 filer). CIK 0001697536. CFO at SS Innovations International, Inc. (SSII) and 3 other issuers. 2 reported Form 4/5 transactions since Sep 2024; latest on Jan 6, 2025. Located in BOCA RATON, FL.

Companies Romano Sarah has filed insider reports for

  • SS Innovations International, Inc. (SSII): Officer, CFO
  • Onconetix, Inc. (ONCO): Director
  • Vicarious Surgical Inc. (RBOT): Officer, Chief Financial Officer
  • Entero Therapeutics, Inc. (ENTO): Officer, Chief Financial Officer
Romano Sarah profile photo

Romano Sarah

CIK: 0001697536

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (100.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (4)

SS Innovations International, Inc. logo
SSII

SS Innovations International, Inc.

Officer
Onconetix, Inc. logo
ONCO

Onconetix, Inc.

Director
Vicarious Surgical Inc. logo
RBOT

Vicarious Surgical Inc.

Officer
Entero Therapeutics, Inc. logo
ENTO

Entero Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Entero Therapeutics, Inc. logo
    ENTO

    Entero Therapeutics, Inc.

    Jan 6, 2025
    Sale
    Direct
    727 shares at avg. $0.64$465.28
  • Entero Therapeutics, Inc. logo
    ENTO

    Entero Therapeutics, Inc.

    Oct 9, 2024
    Sale
    Direct
    476 shares at avg. $0.45$212.296

1-2 of 2